PharmaShots Weekly Snapshot (April 20 -24, 2020)

1. Sanofi Receives the US FDA’s Approval for its MenQuadfi Meningococcal (MenACWY) Conjugate Vaccine

Published: Apr 23, 2020 | Tags: Sanofi, Receives, US, FDA, Approval, MenQuadfi, Meningococcal, MenACWY, Conjugate Vaccine

2.  Takeda to Divest Select OTC and Non-Core Assets in Europe to Orifarm for $670M

Published: Apr 24, 2020 | Tags: Takeda, Divest, Select OTC and Non-Core Assets, Orifarm, $670M

3.  AstraZeneca and MSD Report Results of Lynparza in P-III PROfound Study for BRCA1/2 or ATM-Mutated Metastatic Castration-Resistant Prostate Cancer

Published: Apr 24, 2020 | Tags: AstraZeneca, MSD, Report, Results, Lynparza, P-III, PROfound Study, BRCA1/2, ATM-Mutated, Metastatic, Castration-Resistant, Prostate Cancer

4. Merck & Co. Reports the Resubmission of sBLA to the US FDA for Keytruda (pembrolizumab) Six-Week Dosing Schedule

Published: Apr 23, 2020 | Tags: Merck & Co., Reports, Resubmission, sBLA, US, FDA, Keytruda, pembrolizumab, Six-Week, Dosing Schedule

5.  Janssen Collaborates with Emergent BioSolutions to Accelerate the Manufacturing of its Vaccine Against COVID-19

Published: Apr 23, 2020 | Tags: Janssen, Collaborates, Emergent BioSolutions, Accelerate, Manufacturing, Vaccine, Against, COVID-19

6. Theravance Reports First Patient Dosing in P-I Study with TD-0903 to Treat Patients with Acute Lung Injury Associated with COVID-19

Published: Apr 23, 2020 | Tags: Theravance, Reports, First Patient, Dosing, P-I Study, TD-0903, Treat, Patients, Acute Lung Injury, Associated, COVID-19

7.  Mobidiag Receives Emergency Use Authorization for its Automated COVID-19 Test in Finland

Published: Apr 22, 2020 | Tags: Mobidiag, Receives, Emergency Use Authorization, Automated, COVID-19 Test, Finland

8. LabCorp Receives the US FDA’s Emergency Use Authorization for its COVID-19 At-Home Test Kit

Published: Apr 21, 2020 | Tags: LabCorp, Receives, US, FDA, Emergency Use Authorization, COVID-19, At-Home Test Kit

9. AstraZeneca and Saint Luke’s Mid America Heart Institute to Initiate P-III DARE-19 Evaluating Farxiga Against COVID-19

Published: Apr 23, 2020 | Tags: AstraZeneca, Signs, Clinical Trial Agreement, Saint Luke’s Mid America Heart Institute, Initiate, P-III, DARE-19, Evaluating, Farxiga, Against, COVID-19

10. The European Commission Approves the Merger of Mylan and Upjohn with Conditions

Published: Apr 23, 2020 | Tags: European Commission, Approves, Merger, Mylan, Upjohn, Conditions

11. Valneva and Dynavax Collaborate to Advance the Development of Vaccine Against COVID-19

Published: Apr 22, 2020 | Tags: Valneva, Dynavax, Collaborate, Advance, Development, VLA 2001, Against, COVID-19

12. Sobi’s Affiliate Florio GmbH Launches a Digital Platform to Improve the Lives of Patients with Hemophilia

Published: Apr 22, 2020 | Tags: Sobi, Affiliate, Florio GmbH, Launches, Digital Platform, Improve, Lives, Patients, Hemophilia

13. Pfizer and BioNTech to Commence Clinical Study for COVID-19 in Germany

Published: Apr 22, 2020 | Tags: Pfizer, BioNTech, Commence, Clinical Study, COVID-19, Germany

14. Hope Biosciences Reports its Third US FDA’s Approval for Clinical Trial in COVID-19

Published:  Apr 22, 2020 | Tags: Hope Biosciences, Reports, Third, US, FDA, Approval, Clinical Trial, COVID-19

15. Novartis’ Kymriah (tisagenlecleucel) Receives the US FDA’s Regenerative Medicine Advanced Therapy Designation for Follicular Lymphoma

Published: Apr 22, 2020 | Tags: Novartis, Kymriah, tisagenlecleucel, Receives, US, FDA, Regenerative Medicine Advanced Therapy Designation, Follicular Lymphoma

16. Gilead and Kite Sign a Three Years Agreement with oNKo-innate to Discover Cancer Immunotherapies

Published: Apr 21, 2020 | Tags: Gilead, Kite, Sign, Three Years, Agreement, oNKo-innate, Discover, Cancer Immunotherapies

17.  Bayer Collaborates with the Population Health Research Institute to Identify Treatment for COVID-19

Published: Apr 21, 2020 | Tags: Bayer, Collaborates, Population Health Research Institute, Identify, Treatment, COVID-19

18. Novartis Reports Results of Mayzent (siponimod) in P-III EXPAND Study for Secondary Progressive Multiple Sclerosis

Published: Apr 21, 2020 | Tags: Novartis, Reports, Results, Mayzent, siponimod, P-III, EXPAND Study, Secondary Progressive Multiple Sclerosis

19. Sangamo Signs an Exclusive License Agreement with Mogrify for iPSC and ESC-Derived Regulatory T-Cells

Published: Apr 21, 2020 | Tags: Sangamo, Signs, Exclusive, License Agreement, Mogrify, iPSC, ESC-Derived, Regulatory T-Cells

20.  Noxopharm Anticipates the US FDA’s Approval for Evaluating Veyonda in a Clinical Study for COVID-19

Published:  Apr 21, 2020 | Tags:  Noxopharm, Anticipates, US, FDA, Approval, Evaluating, Veyonda, Clinical Study, COVID-19

21. Roche’s cobas HPV Test Receives the US FDA’s Approval for cobas 6800/8800 System to Identify Women at Risk for Cervical Cancer

Published: Apr 21, 2020 | Tags: Roche, cobas HPV Test, Receives, US, FDA, Approval, cobas 6800/8800 System, Identify Women, Risk, Cervical Cancer

22.  Cue Biopharma Signs Clinical Trial Collaboration with Merck to Evaluate CUE-101 + Keytruda (pembrolizumab) as 1L Treatment for HPV+ Recurrent/Metastatic Head and Neck Cancer

Published: Apr 20, 2020 | Tags: Cue Biopharma, Signs, Clinical Trial Collaboration, Merck, Evaluate, CUE-101, Keytruda, pembrolizumab, 1L, Treatment, HPV+, Recurrent/Metastatic, Head and Neck Cancer

23. RedHill Biopharma Collaborates with NIAID to Investigate RHB-107 (upamostat, WX-671) Against COVID-19

Published: Apr 20, 2020 | Tags: RedHill Biopharma, Collaborates, NIAID, RHB-107, upamostat, WX-671, Against, COVID-19

24.   Alexion to Initiate P-III Study of Ultomiris (ravulizumab-cwvz) in Hospitalized Patients with Severe COVID-19

Published: Apr 20, 2020 | Tags: Alexion, Initiate, P-III, Study, Ultomiris, ravulizumab-cwvz, Hospitalized Patients, Severe, COVID-19

25.  Otsuka Signs a Development and Commercialization Agreement with Esperion for Nexletol (bempedoic acid) and Nexlizet (bempedoic acid and ezetimibe) in Japan

Published: Apr 20, 2020 | Tags: Otsuka, Signs, Development, Commercialization, Agreement, Esperion, Nexletol, bempedoic acid,  Nexlizet, bempedoic acid and ezetimibe, Japan

26. Fosun Pharma Receives the US FDA’s EUA for its COVID-19 RT-PCR Detection Kit

Published: Apr 19, 2020 | Tags: Fosun Pharma, Receives, US, FDA, EUA, COVID-19 RT-PCR Detection Kit

27. Incyte Initiates P-III RUXCOVID Study Evaluating Jakafi (ruxolitinib) to Treat Patients with COVID-19 Associated Cytokine Storm

Published: Apr 17, 2020 | Tags: Incyte, Initiates, P-III, RUXCOVID Study, Evaluating, Jakafi, ruxolitinib, Treat, Patients, COVID-19 Associated Cytokine Storm

28. Roche Reports the FDA and EMA’s Acceptance of sBLA for Ocrevus Shorter 2-Hour Infusion Time

Published: Apr 20, 2020 | Tags: Roche, Reports, FDA, EMA, Acceptance, sBLA, Ocrevus, Shorter 2-Hour, Infusion Time

29. Novartis Signs an Agreement with the US FDA to Evaluate Hydroxychloroquine in Patients with COVID-19

Published: Apr 20, 2020 | Tags: Novartis, Signs, Agreement, US, FDA, Evaluate, Hydroxychloroquine, Patients, COVID-19

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post